Under 40s to be offered alternative to AZ vaccine
Link to rare blood clots leads to shift in vaccination programme for younger age groups. …
He added: “As Covid-19 rates continue to come under control, we are advising that adults aged 18- 39 years with no underlying health conditions are offered an alternative to the Oxford-AstraZeneca vaccine, if available, and if it does not cause delays in having the vaccine.”